mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |